MyAverix Finance
US · Healthcare
NKGen Biotech, Inc. Common Stock (NKGN)
Biotechnology
NKGen Biotech, Inc. Common Stock (NKGN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NKGN
NKGen Biotech, Inc. Common Stock (NKGN) — FAQ
What is NKGN's P/E ratio?
The price-to-earnings (P/E) ratio for NKGen Biotech, Inc. Common Stock (NKGN) is 18.00 (data as of 2026-03-24).
Does NKGen Biotech, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for NKGen Biotech, Inc. Common Stock (NKGN). Check the MyAverix Finance app for the latest dividend data.
What sector is NKGen Biotech, Inc. Common Stock in?
NKGen Biotech, Inc. Common Stock (NKGN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NKGN listed on?
NKGN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.